|本期目录/Table of Contents|

[1]刘 龙,赵景旺,陈旨娟,等.探讨胶质母细胞瘤病变范围在MRI增强和MET-PET中的差异性[J].天津医科大学学报,2017,23(01):32-35.
 LIU Long,ZHAO Jing-wang,CHEN Zhi-juan,et al.Differece between methionine PET and MR enhancement in? the range of glioblastoma multiforme[J].Journal of Tianjin Medical University,2017,23(01):32-35.
点击复制

探讨胶质母细胞瘤病变范围在MRI增强和MET-PET中的差异性(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
23卷
期数:
2017年01期
页码:
32-35
栏目:
临床医学
出版日期:
2017-01-16

文章信息/Info

Title:
Differece between methionine PET and MR enhancement in? the range of glioblastoma multiforme
文章编号:
1006-8147(2017)01-0032-04
作者:
刘 龙1赵景旺1陈旨娟2贾 源1郑金平1王威汉1王增光2杨卫东1

(1.天津医科大学总医院神经外科,天津300052;2.天津市神经病学研究所,天津300052)

Author(s):
LIU Long1 ZHAO Jing-wang1 CHEN Zhi-juan2 JIA Yuan1 ZHENG Jin-ping1 WANG Wei-han1WANG Zeng-guang2 YANG Wei-dong1
(1.Department of Neurosurgery,General Hospital,Tianjin Medical University,Tianjin 300052, China;2. Tianjin Neurological Institute, Tianjin 300052, China)
关键词:
共振成像PET/CT 蛋氨酸 胶质母细胞瘤
Keywords:

magnetic resonance imaging positron emission tomography and computed tomography methionine glioblastoma

分类号:
R651
DOI:
-
文献标志码:
A
摘要:
目的: 探讨胶质母细胞瘤病变范围在MRI增强和MET-PET影像中的差异性。方法: 回顾性分析5例经手术确诊的胶质母细胞瘤患者临床资料。收集患者术前MRI 增强(3D扫描)和PET/CT检查(MET示踪剂)的影像资料。以 MRI增强3D-T1序列为参考,将PET图像与其配准。使用MRIcron软件勾画对比PET高摄取区和MRI增强区的病变范围,分析胶质母细胞瘤PET高摄取区与MRI增强区的分布特点。结果: 5例患者病理结果均为胶质母细胞瘤(WHO Ⅳ级)。经过影像配准对比发现,胶质母细胞瘤病变的MET高摄取范围大于MRI增强范围,MET高摄取图像整体呈偏心性、不均一性,MET高摄取区薄弱甚至缺如的部分,常对应着MRI线样强化、实体组织较少的病变部位。结论: 将MRI增强和PET影像配准对比分析,有助于发现胶质母细胞瘤整体的偏心性、不均一性,为最大范围手术切除肿瘤提供辅助指导作用。
Abstract:
Objective: To explore the difference between the metabolically active tumors assessed by positron emission tomography and the area of enhancement magnetic resonance imaging in patients with newly diagnosed glioblastoma(GBM). Methods: Five patients with newly diagnosed GBM were included in this study. MET-PET and enhanced MRI were analyzed in MRIcron software, including coregistration and overlaying. The glioblastoma lesion distribution was compared and its discrepancy was concluded between PET and MRI enhancement. Results: All five patients were confirmed as glioblastoma multiforme by histopathological diagnosis. Volume the metabolically active tumor as shown by a MET uptake index of ≥1.3 was larger than the that of MRI enhancement. The image of MET was eccentric and asymmetric in general, and MET weak position was in correspondence to MRI linear enhancement or tumor with necrotic tissue. Conclusion: Coregistration and analysis of MRI with MET-PET may be helpful to determine that GBM is eccentric and asymmetric, and may also need further quantitative research to become a more general approach.

参考文献/References:

[1]Louis D N, Ohgaki H, Wiestler O D, et al. The 2007 WHO classification of tumours of the central nervous system[J].Acta Neuropathol,2007,114(2):97
[2]Valérie R, Sonia Z, Amélie D, et al. French Brain Tumor DataBase: 5‐Year Histological Results on 25?756 Cases[J]. Brain Pathology, 2011, 21(6):633
[3]Ricard D, Idbaih A, Ducray F, et al. Primary brain tumours in adults[J].Lancet,2012,379(9830):1984
[4]Woehrer A, Bauchet L, Barnholtz-Sloan J S.Glioblastoma survival: has it improved Evidence from population-based studies[J].Curr Opin Neurol,2014,27(6):666
[5]Stupp R, Hegi M E, Gilbert M R, et al. Chemoradiotherapy in malignant glioma: Standard of care and future directions[J].J Clin Oncol,2007,25(26):4127
[6]Miwa K, Shinoda J, Yano H, et al. Discrepancy between lesion distributions on methionine PET and Mr images in patients with glioblastoma multiforme: insight from a PET and Mr fusion image study[J]. J Neurol Neurosurg Psychiatry, 2004,75(10):1457
[7]Arbizu J, Tejada S, Marti-Climent J M, et al. Quantitative volumetric analysis of gliomas with sequential MRI and 11C-methionine PET assessment: patterns of integration in therapy planning[J].Eur J Nucl Med Mol Imaging,2012,39(5):771
[8]王如,钱立庭,汪世存,等. 基于11C-MET PET-CT与MRI对脑胶质瘤精确放疗GTV勾画的比较研究[J].中华放射肿瘤学杂志,2014,23(2):143
[9]Kelly P J, Daumasduport C, Kispert D B, et al. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.[J]. Journal of Neurosurgery, 2009, 66(6):865
[10]Sanai N, Berger M S. Glioma extent of resection and its impact on patient outcome[J].Neurosurgery,2008,62(4):753
[11]于雷,王莹莹,车现锋,等. 11C-蛋氨酸PET-CT在诊断脑胶质瘤复发和三维适形放疗靶区规划中的临床应用[J].中国临床医学影像杂志,2013,24(6):385
[12]Grosu A L, Weber W A, Riedel E, et al. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.[J]. International Journal of Radiation Oncology Biology Physics, 2005, 63(1):64
[13]Kracht L W, Miletic H, Busch S, et al. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology[J].Clin Cancer Res,2004,10(21):7163
[14]del Amo E M, Urtti A, Yliperttula M. Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2[J].Eur J Pharm Sci,2008,35(3):161
[15]Kim D K, Kim I J, Hwang S, et al. System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells[J].Neurosci Res,2004,50(4):437
[16]Di I A, Grizzi F M, Colombo P, et al. Correlation of microvascular fractal dimension with positron emission tomography ((11)C)-methionine uptake in glioblastoma multiforme: preliminary findings[J]. Microvascular Research, 2010, 80(2):267
[17]Okita Y, Kinoshita M, Goto T, et al.C-11-methionine uptake correlates with tumor cell density rather than with microvessel density in glioma: A stereotactic image-histology comparison[J].Neuroimage,2010,49(4):2977
[18]Almeida J P, Chaichana K L, Rincon-Torroella J, et al. The value of extent of resection of glioblastomas: Clinical evidence and current approach[J]. Current Neurology and Neuroscience Reports, 2015, 15(2):1

相似文献/References:

[1]季艳会,谭 建,张桂芝,等.全身广泛骨转移为首发症状的甲状腺微小乳头状癌1例[J].天津医科大学学报,2015,21(04):314.
[2]周 雯,朱 湘,王 健,等.18F-FDG PET/CT显像在食管癌分期时发现同时性重复癌的价值[J].天津医科大学学报,2015,21(05):404.
 ZHOU Wen,ZHU Xiang,WANG Jian,et al. 18F-FDG PET/CT in detecting synchronous primary neoplasms for initial stage of esophageal cancer[J].Journal of Tianjin Medical University,2015,21(01):404.
[3]贾朝阳,徐文贵,朱 磊,等.18F-FDG PET/CT在结直肠癌术后预后中的应用[J].天津医科大学学报,2019,25(04):342.
 JIA Zhao-yang,XU Wen-gui,ZHU Lei,et al.The application of 18F-FDG PET/CT in the prognosis of postoperative colorectal cancer[J].Journal of Tianjin Medical University,2019,25(01):342.

备注/Memo

备注/Memo:

作者简介 刘龙(1989-),男,住院医师,硕士在读,研究方向:立体定向与功能神经外科;通信作者:杨卫东,E-mail: yangweidongshine@sina.com.



?

更新日期/Last Update: 2017-01-16